WallStreetZenWallStreetZen

NASDAQ: TOI
Oncology Institute Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for TOI

Based on 1 analyst offering 12 month price targets for Oncology Institute Inc.
Min Forecast
$2.50+103.25%
Avg Forecast
$2.50+103.25%
Max Forecast
$2.50+103.25%

Should I buy or sell TOI stock?

Based on 1 analyst offering ratings for Oncology Institute Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TOI stock forecasts and price targets.

TOI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-26

1 of 1

Forecast return on equity

Is TOI forecast to generate an efficient return?

Forecast return on assets

Is TOI forecast to generate an efficient return on assets?

TOI revenue forecast

What is TOI's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$412.5M+27.23%
Avg 2 year Forecast
$482.8M+48.9%
TOI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TOI revenue growth forecast

How is TOI forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
27.23%
Industry
6.63%
Market
13.58%
TOI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TOI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TOI vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
TOI$1.23$2.50+103.25%Strong Buy
CCEL$7.37N/AN/A
CCM$0.58N/AN/A
PIII$0.50$4.50+798.20%Strong Buy
AMS$2.91N/AN/A
View Top Medical Care Facility Stocks

Oncology Institute Stock Forecast FAQ

Is Oncology Institute Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: TOI) stock is to Strong Buy TOI stock.

Out of 1 analyst, 1 (100%) are recommending TOI as a Strong Buy, 0 (0%) are recommending TOI as a Buy, 0 (0%) are recommending TOI as a Hold, 0 (0%) are recommending TOI as a Sell, and 0 (0%) are recommending TOI as a Strong Sell.

If you're new to stock investing, here's how to buy Oncology Institute stock.

What is TOI's revenue growth forecast for 2024-2025?

(NASDAQ: TOI) Oncology Institute's forecast annual revenue growth rate of 27.23% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.63%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.58%.

Oncology Institute's revenue in 2024 is $324,239,000.On average, 1 Wall Street analysts forecast TOI's revenue for 2024 to be $30,656,309,300, with the lowest TOI revenue forecast at $30,656,309,300, and the highest TOI revenue forecast at $30,656,309,300.

In 2025, TOI is forecast to generate $35,877,535,130 in revenue, with the lowest revenue forecast at $35,877,535,130 and the highest revenue forecast at $35,877,535,130.

What is TOI's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: TOI) forecast ROA is N/A, which is lower than the forecast US Medical Care Facilities industry average of 6.11%.

What is TOI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TOI price target, the average TOI price target is $2.50, with the highest TOI stock price forecast at $2.50 and the lowest TOI stock price forecast at $2.50.

The Wall Street analyst predicted that Oncology Institute's share price could reach $2.50 by Feb 26, 2025. The average Oncology Institute stock price prediction forecasts a potential upside of 103.25% from the current TOI share price of $1.23.

What is TOI's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: TOI) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.